Stage III Verrucous Carcinoma of the Larynx Terminated Phase 2 Trials for Afatinib (DB08916)

IndicationStatusPhase
DBCOND0029516 (Stage III Verrucous Carcinoma of the Larynx)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs